Jimmy Kong

机构：Pfizer (United States)

发表论文 20 篇 · 总被引 512 次 · h-index 11

代表论文

Expression of the Rat Adrenomedullin Receptor or a Putative Human Adrenomedullin Receptor Does Not Correlate with Adrenomedullin Binding or Functional Response (1998 · Biochemical and Biophysical Research Communications · 被引 97)
A Novel Sodium-Hydrogen Exchanger Isoform-1 Inhibitor, Zoniporide, Reduces Ischemic Myocardial Injury in Vitro and in Vivo (2001 · Journal of Pharmacology and Experimental Therapeutics · 被引 75)
Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate (2014 · ACS Medicinal Chemistry Letters · 被引 71)
3‘-Aminoadenosine-5‘-uronamides: Discovery of the First Highly Selective Agonist at the Human Adenosine A 3 Receptor (2002 · Journal of Medicinal Chemistry · 被引 59)
An inverse agonist of orphan receptor GPR61 acts by a G protein-competitive allosteric mechanism (2023 · Nature Communications · 被引 38)
Zoniporide: a potent and highly selective inhibitor of human Na+/H+ exchanger-1 (2002 · European Journal of Pharmacology · 被引 38)